HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Axel Haverich Martin Strüber Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Warnecke, G. Articles by Strüber, M. Search for Related Content PubMed PubMed Citation Articles by Warnecke, G. Articles by Strüber, M. Related Collections Lung - transplantation

Eur J Cardiothorac Surg 2005;28:454-460
© 2005 Elsevier Science NL

Original articles

Tacrolimus versus cyclosporine induction therapy in pulmonary transplantation in miniature swine

^a Division of Thoracic and Cardiovascular Surgery, Hannover Medical School, Carl-Neuberg-Str. 1, 30623 Hannover, Germany
^b Department of Respiratory Medicine, Hannover Medical School, Carl-Neuberg-Str. 1, 30623 Hannover, Germany

Received 14 April 2005; accepted 18 May 2005.

^* Corresponding author. Tel: +49 511 532 6588; fax: +49 511 532 8446. (Email: strueber{at}thg.mh-hannover.de).

Abstract

Objective: Tacrolimus has been shown to provide superior immunosuppression in various solid organ transplant settings. The purpose of our study was to compare the survival of porcine lung allografts after induction with either cyclosporine A (CsA) or tacrolimus. Methods: Single lung transplantation from MHC mismatched donors was performed in 10 minipigs. Immunosuppression included 1.5mg/kg per day methylprednisolone and 1.0mg/kg per day azathioprine. CsA (n=5) was adjusted to trough levels of 300–500ng/ml, tacrolimus (n=5) was adjusted to 16–26ng/ml. All immunosuppressive drugs were discontinued on postoperative day (POD) 28. Allograft survival was monitored by sequential chest radiographs, bronchoscopy and transbronchial biopsy histology. Peripheral blood leukocytes were scanned for donor chimerism and CD3, CD4, CD8 and CD25 expression. Results: The animals survived a 4-week course of immunosuppression without radiological or histological signs of rejection on POD 28. Median allograft survival in CsA-treated animals was 55±15 days and all animals rejected their grafts within 42 days after withdrawal of immunosuppression. In tacrolimus-treated animals, median survival was 152±65 days with the longest survivor being electively sacrificed on POD 390 (P=0.0064). The degree of donor leukocyte chimerism and the frequency of CD4⁺CD25⁺T-cells were higher in the tacrolimus group, however, these differences were not statistically significant. Conclusion: The results of our study show that primary immunosuppression with tacrolimus is superior to cyclosporine after pulmonary allotransplantation in a large animal model.

Key Words: Lung transplantation • Tacrolimus • Cyclosporine • Primary immunosuppression